Le Travenues Technology Share Price Rises 8% After Strong Q4 FY25 Results

On May 15, 2025, shares of Le Travenues Technology Ltd, known as ixigo, surged by 8.1% to hit a high of ₹181.30 on the BSE. This rise came a day after the company announced its strong financial results for the January–March 2025 quarter (Q4 FY25).
 

As of 10:48 AM, the stock trimmed some gains but was still up 4.41% at ₹175.05. At the same time, the BSE Sensex was slightly up by 0.04% at 81,362.24. ixigo's market capitalisation stood at ₹6,828.89 crore. Its 52-week high and low are ₹196.45 and ₹118.65, respectively.

Q4 FY25 Financial Highlights

• Net Profit: ₹16.8 crore, up 128% from ₹7.3 crore in Q4 FY24.
• Revenue from Operations: ₹284 crore, up 72% from ₹165 crore last year.
• EBITDA: ₹30.7 crore, up 64% year-on-year.
• Gross Transaction Value (GTV): Grew by 65% compared to the previous year.
• Contribution Margin (CM): Jumped 69% YoY to ₹120.9 crore in Q4 FY25.

Read More, BEML Shares to Trade Ex-Date on May 15: Interim Dividend of ₹10.    

About ixigo

Founded in 2007, ixigo is a travel-tech company that helps Indian travellers plan, book, and manage trips across trains, flights, buses, hotels, and cabs. It operates popular travel platforms like ixigo, ConfirmTkt, and AbhiBus, which allow users to book tickets and access various travel tools and services. The company uses AI-based technology and crowd-sourced data to assist users in making smarter travel decisions. 

In FY24, ixigo reported over 48 crore Annual Active Users, making it one of India’s leading online travel agencies (OTA), especially for the Next Billion Users segment.

Conclusion

ixigo’s strong Q4 performance reflects robust growth in user engagement and efficient tech-driven services. With rising revenues and profits, the company continues to solidify its position as a top online travel platform catering to India’s next billion users.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.         

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.